Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Bio-equivalence Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

Compare the median number of passes required to establish a diagnosis

Outcome Time Frame:

6 months

Safety Issue:

No

Principal Investigator

Shyam Varadarajulu, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Alabama at Birmingham

Authority:

United States: Institutional Review Board

Study ID:

F110506010

NCT ID:

NCT01394159

Start Date:

July 2011

Completion Date:

December 2011

Related Keywords:

• Pancreatic Neoplasm
• passes required to establish diagnosis
• Neoplasms
• Pancreatic Neoplasms